Dr Reddys Laboratories Share Price Today - Live Blog for August 20, 2025

Dr Reddys Laboratories Ltd's share price stayed unchanged, currently trading at ₹1,245.00. The stock has a PE ratio of 18.2900, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

With a remarkable 0.01% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,245.80. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.2900, while the industry's PE ratio is 34.8748.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.20%, reaching a current market price of ₹1,244.35. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,246.80. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.2900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.02% upswing and is currently trading at ₹1,247.30, indicating strong market sentiment.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.05% uptick in its share price. As a result, it's now actively trading at ₹1,248.55 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.05%. With its current market price standing at ₹1,248.55 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd share price has declined by -0.02%, and it's currently trading at ₹1,248.05. The stock maintains a PE of 18.2900, while the industry PE is 34.8748, prompting discussions about its valuation.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,248.25. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a -0.14% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,248.00. The stock has a PE ratio of 18.2900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has surged by 0.09%, and it is currently trading at ₹1,249.70. Additionally, the stock maintains a PE ratio of 18.2900, while the industry PE is 34.8748.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.09% increase. Presently, it is actively trading at ₹1,249.70.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.03%, reaching the current market price of ₹1,248.55. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.10% increase. Presently, it is actively trading at ₹1,249.90.

With a -0.40% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,243.20. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.2900, while the industry PE is 34.8748.

The stock of Dr Reddys Laboratories Ltd suffered a -0.40% drop, and it's now trading at ₹1,243.20 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd shares experienced a -0.02% reduction, with the current market price at ₹1,248.15. Investors are carefully considering their positions and seeking insights into the stock's future performance.

After a -0.00% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,250.00. The stock has a PE ratio of 18.2900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.17% boost, with the current market value at ₹1,250.00 per share. This surge has not gone unnoticed by investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.23%. At this moment, it's actively trading at ₹1,247.90, presenting an enticing opportunity for those in the market.

Following a noteworthy 0.19% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,246.50. When it comes to valuation, this stock has a PE ratio of 18.2900, with the industry PE ratio at 34.8748.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.12% drop, and it's now trading at ₹1,243.40 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.22%, with its current market value per share resting at ₹1,244.30. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.12%, and as of now, it's trading at ₹1,240.60 per share. This upward trajectory is attracting keen interest from investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.05% decline and is currently trading at ₹1,239.85 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Dr Reddys Laboratories Ltd suffered a -0.31% decline, and it currently trades at ₹1,240.50 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Demonstrating a commendable 0.03% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,244.40. In terms of valuation, the stock maintains a PE ratio of 18.2900, while the industry PE ratio stands at 34.8748.